Recombinant adenoviral (rAd) vectors are highly suitable for efficient genetic modification of dendritic cells (DC). In certain cases, the high immunogenicity of rAd may be a disadvantage. This chapter describes the essential aspects of optimal rAd-mediated gene transfer into DC, discusses the consequences of the immunogenicity of rAd vectors, and provides suggestions to minimize these complications.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1385/1-59259-862-5:083 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!